Skip to main content
. 2014 Oct 21;44(11):1371–1385. doi: 10.1111/cea.12400

Table 2.

Summary of PK parameters for (a) the intravenous trial and (b) the subcutaneous trial

Cohort 1 0.1 mg/kg Cohort 2 0.3 mg/kg Cohort 3 1.0 mg/kg Cohort 4 3 mg/kg Cohort 5 3 mg/kg IgE > 1000 IU/mL Cohort 6 10 mg/kg
n = 6 n = 6 n = 8 n = 9 n = 1 n = 6
(a)
Cmax (μg/mL) Mean (SD) 1.94 (0.47) 5.54 (0.62) 19.3 (6.8) 44.6 (6.63) 59.1 158 (24.2)
Range 1.34, 2.63 4.89, 6.32 3.84, 26.4 34.7, 54.0 NC 119, 184
AUC0–113 days (h μg/mL) Mean (SD) 124 (62.2) 608 (95.4) 2565 (1313) 9245 (2244) 6342 30269 (6113)
Range 67.9, 225 469, 743 71.8, 4143 5809, 13427 NC 20064, 38435
AUCinf (h μg/mL) Mean (SD) 170 (135) 635 (110) 2794 (1171) 9696 (2043) 6675 31072 (6617)
Range 74.3, 428 473, 788 429, 4363 7687, 13627 NC 20219, 40445
T½ (days) Mean (SD) 2.8 (2.4) 4.5 (1.43) 8.2 (5.7) 17.4 (4.7) 13.8 23.1 (7.1)
Range 1, 7.7 2.5, 6.5 2.8, 20 12.4, 25.8 NC 15, 33
Cohort 1 0.2 mg/kg Cohort 2 0.6 mg/kg Cohort 3 2 mg/kg Cohort 4 2 mg/kg IgE > 700 IU/mL Cohort 6 4 mg/kg
n = 8 n = 7 n = 37 n = 6 n = 6
(b)
Cmax (μg/mL) Mean (SD) 1.86 (0.49) 6.00 (1.83) 20.7 (5.05) 16.8 (5.67) 22.1 (1.92)
Range 1.04, 2.75 3.86, 8.81 11.2, 31.1 8.58, 25.0 19.4, 25.1
Tmax (days) Median 3.92 2.00 3.96 4.0 4.04
Range 2.00, 4.12 2.00, 5.38 1.96, 14.0 4.00, 4.34 2.00, 4.12
AUC0–14 days (h μg/mL) Mean (SD) 512 (138) 1740 (645) 5500 (1370) 4120 (1810) 5900 (449)
Range 264, 736 1120, 2740 2810, 7870 1990, 7210 5450, 6630
T½ (days) Mean (SD) 14.6 (3.30) 23.2 (7.44) 25.9 (7.37) 13.0 (5.48) 26.2 (8.12)
Range 10.3, 21.7 16.3, 34.7 11.9, 45.1 7.54, 21.7 16.2, 34.8

AUC, area under the curve; AUCinf, area under the curve from time zero to infinity; Cmax, peak serum concentration; SD, standard deviation; Tmax, time to reach peak serum concentration; T½, half-life in serum; AUC, area under the curve; Cmax, peak serum concentration; NC, not calculable; SD, standard deviation; T1/2, half-life in serum.